Defining cell and gene therapy financial disruption
FoCUS studied the distinguishing components of new durable therapies in clinical development and created the Pipeline Analysis Model. Customize this model for your organization.
Financial solutions for cell and gene therapies
Access to cell and gene therapies can be improved with a financial strategy. Check out the Precision Financing Solutions identified by FoCUS when developing your strategy.
Understanding all stakeholder perspectives
Patients, payers, and developers are on a shared journey to access cell and gene therapies and maintain financial stability. Understand your fellow stakeholders’ perspectives as you address issues from your point of view.